Dyslipidemia is a common finding in patients with thyroid disease, explained by the adverse
effects of thyroid hormones in almost all steps of lipid metabolism. Not only overt but also …

A kaleidoscope of coagulation disorders have been reported in patients with thyroid
dysfunctions. Globally, these disorders involve both primary and secondary hemostasis and …

Various abnormalities of coagulation and fibrinolysis, ranging from subclinical laboratory
abnormalities to clinically significant disorders of hemostasis, but rarely major hemorrhage …

Background Several hemostatic abnormalities have been described in hypothyroidism, such
as modification of coagulation proteins and bleeding tendency. Although thyroid hormone …

Background: Several hemostatic abnormalities have been reported in hyperthyroidism, but
the overall effect of thyroid hormone excess on coagulation and fibrinolysis is unclear …

Subclinical hypothyroidism (SH) is a frequent condition affecting millions of people around
the world. Defined by increased thyrotropin-stimulating hormone (TSH) and accompanied by …

The hemostatic balance is a complex system where the delicate equilibrium is regulated by
several factors including hormones. A variety of endocrine disorders have been reported to …

Whether or not subclinical hyperthyroidism (SCH) should be treated, remains a matter of
debate because there are no randomized clinical trials answering the question if treatment …

Cerebral vein and sinus thrombosis (CVST) is an uncommon disease with an estimated
incidence of 4 per 1,000,000 per year and with a mortality rate ranges from 5% to 30%[1] …

Aim: To investigate the relationship between free triiodothyronine (FT3) and the international
normalized ratio (the ratio of the prothrombin time of a patient to the normal sample, INR) in …